Cargando…

Antidepressant but Not Prophylactic Ketamine Administration Alters Calretinin and Calbindin Expression in the Ventral Hippocampus

Ketamine has been found to have rapid, long-lasting antidepressant effects in treatment-resistant (TR) patients with major depressive disorder (MDD). Recently, we have also shown that ketamine acts as a prophylactic to protect against the development of stress-induced depressive-like behavior in mic...

Descripción completa

Detalles Bibliográficos
Autores principales: LaGamma, Christina T., Tang, William W., Morgan, Ashlea A., McGowan, Josephine Cecelia, Brachman, Rebecca A., Denny, Christine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232342/
https://www.ncbi.nlm.nih.gov/pubmed/30459554
http://dx.doi.org/10.3389/fnmol.2018.00404
_version_ 1783370386100977664
author LaGamma, Christina T.
Tang, William W.
Morgan, Ashlea A.
McGowan, Josephine Cecelia
Brachman, Rebecca A.
Denny, Christine A.
author_facet LaGamma, Christina T.
Tang, William W.
Morgan, Ashlea A.
McGowan, Josephine Cecelia
Brachman, Rebecca A.
Denny, Christine A.
author_sort LaGamma, Christina T.
collection PubMed
description Ketamine has been found to have rapid, long-lasting antidepressant effects in treatment-resistant (TR) patients with major depressive disorder (MDD). Recently, we have also shown that ketamine acts as a prophylactic to protect against the development of stress-induced depressive-like behavior in mice, indicating that a preventative treatment against mental illness using ketamine is possible. While there is significant investigation into ketamine’s antidepressant mechanism of action, little is known about ketamine’s underlying prophylactic mechanism. More specifically, whether ketamine’s prophylactic action is molecularly similar to or divergent from its antidepressant action is entirely unknown. Here, we sought to characterize immunohistochemical signatures of cell populations governing ketamine’s antidepressant and prophylactic effects. 129S6/SvEv mice were treated with saline (Sal) or ketamine (K) either before a social defeat (SD) stressor as a prophylactic, or after SD as an antidepressant, then subsequently assessed for depressive-like behavior. Post-fixed brains were processed for doublecortin (DCX), calretinin (CR) and calbindin (CB) expression. The number of DCX(+) neurons in the dentate gyrus (DG) of the hippocampus (HPC) was not affected by prophylactic or antidepressant ketamine treatment, while the number of CR(+) neurons in the ventral hilus increased with antidepressant ketamine under SD conditions. Moreover, antidepressant, but not prophylactic ketamine administration significantly altered CR and CB expression in the ventral HPC (vHPC). These data show that while antidepressant ketamine treatment mediates some of its effects via adult hippocampal markers, prophylactic ketamine administration does not, at least in 129S6/SvEv mice. These data suggest that long-lasting behavioral effects of prophylactic ketamine are independent of hippocampal DCX, CR and CB expression in stress-susceptible mice.
format Online
Article
Text
id pubmed-6232342
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62323422018-11-20 Antidepressant but Not Prophylactic Ketamine Administration Alters Calretinin and Calbindin Expression in the Ventral Hippocampus LaGamma, Christina T. Tang, William W. Morgan, Ashlea A. McGowan, Josephine Cecelia Brachman, Rebecca A. Denny, Christine A. Front Mol Neurosci Neuroscience Ketamine has been found to have rapid, long-lasting antidepressant effects in treatment-resistant (TR) patients with major depressive disorder (MDD). Recently, we have also shown that ketamine acts as a prophylactic to protect against the development of stress-induced depressive-like behavior in mice, indicating that a preventative treatment against mental illness using ketamine is possible. While there is significant investigation into ketamine’s antidepressant mechanism of action, little is known about ketamine’s underlying prophylactic mechanism. More specifically, whether ketamine’s prophylactic action is molecularly similar to or divergent from its antidepressant action is entirely unknown. Here, we sought to characterize immunohistochemical signatures of cell populations governing ketamine’s antidepressant and prophylactic effects. 129S6/SvEv mice were treated with saline (Sal) or ketamine (K) either before a social defeat (SD) stressor as a prophylactic, or after SD as an antidepressant, then subsequently assessed for depressive-like behavior. Post-fixed brains were processed for doublecortin (DCX), calretinin (CR) and calbindin (CB) expression. The number of DCX(+) neurons in the dentate gyrus (DG) of the hippocampus (HPC) was not affected by prophylactic or antidepressant ketamine treatment, while the number of CR(+) neurons in the ventral hilus increased with antidepressant ketamine under SD conditions. Moreover, antidepressant, but not prophylactic ketamine administration significantly altered CR and CB expression in the ventral HPC (vHPC). These data show that while antidepressant ketamine treatment mediates some of its effects via adult hippocampal markers, prophylactic ketamine administration does not, at least in 129S6/SvEv mice. These data suggest that long-lasting behavioral effects of prophylactic ketamine are independent of hippocampal DCX, CR and CB expression in stress-susceptible mice. Frontiers Media S.A. 2018-11-06 /pmc/articles/PMC6232342/ /pubmed/30459554 http://dx.doi.org/10.3389/fnmol.2018.00404 Text en Copyright © 2018 LaGamma, Tang, Morgan, McGowan, Brachman and Denny. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
LaGamma, Christina T.
Tang, William W.
Morgan, Ashlea A.
McGowan, Josephine Cecelia
Brachman, Rebecca A.
Denny, Christine A.
Antidepressant but Not Prophylactic Ketamine Administration Alters Calretinin and Calbindin Expression in the Ventral Hippocampus
title Antidepressant but Not Prophylactic Ketamine Administration Alters Calretinin and Calbindin Expression in the Ventral Hippocampus
title_full Antidepressant but Not Prophylactic Ketamine Administration Alters Calretinin and Calbindin Expression in the Ventral Hippocampus
title_fullStr Antidepressant but Not Prophylactic Ketamine Administration Alters Calretinin and Calbindin Expression in the Ventral Hippocampus
title_full_unstemmed Antidepressant but Not Prophylactic Ketamine Administration Alters Calretinin and Calbindin Expression in the Ventral Hippocampus
title_short Antidepressant but Not Prophylactic Ketamine Administration Alters Calretinin and Calbindin Expression in the Ventral Hippocampus
title_sort antidepressant but not prophylactic ketamine administration alters calretinin and calbindin expression in the ventral hippocampus
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232342/
https://www.ncbi.nlm.nih.gov/pubmed/30459554
http://dx.doi.org/10.3389/fnmol.2018.00404
work_keys_str_mv AT lagammachristinat antidepressantbutnotprophylacticketamineadministrationalterscalretininandcalbindinexpressionintheventralhippocampus
AT tangwilliamw antidepressantbutnotprophylacticketamineadministrationalterscalretininandcalbindinexpressionintheventralhippocampus
AT morganashleaa antidepressantbutnotprophylacticketamineadministrationalterscalretininandcalbindinexpressionintheventralhippocampus
AT mcgowanjosephinececelia antidepressantbutnotprophylacticketamineadministrationalterscalretininandcalbindinexpressionintheventralhippocampus
AT brachmanrebeccaa antidepressantbutnotprophylacticketamineadministrationalterscalretininandcalbindinexpressionintheventralhippocampus
AT dennychristinea antidepressantbutnotprophylacticketamineadministrationalterscalretininandcalbindinexpressionintheventralhippocampus